GH Research
GHRS
34 hedge funds and large institutions have $594M invested in GH Research in 2021 Q2 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
56.48% more ownership
Funds ownership: 0% → 56.48% (+56%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$189M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$60.8M |
| 3 |
RI
RTW Investments
New York
|
+$44.3M |
| 4 |
O
OrbiMed
New York
|
+$29.2M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$27.8M |
Top Sellers
GHRS Hedge Fund Activity: Q2 2021 in Review
34 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in GH Research (GHRS) for Q2 2021, worth a combined $594M.
Buyers outnumbered sellers: 34 funds opened new GHRS positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was BVF Inc, opening a new position worth an estimated $189M.
- 34 institutional investors held GH Research (GHRS) as of Q2 2021, up from 0 in Q1 2021.
- Funds reported $594M of GH Research stock for Q2 2021.
- 34 funds opened new GH Research positions in Q2 2021 and 0 closed out, a net change of +34 holders.
- The largest GH Research buyer in Q2 2021 was BVF Inc, an estimated $189M added.
Based on aggregated 13F filings for Q2 2021.